1-3 of 3
Michael F Quinn, MD
Close
Sort by
Journal Articles

RNA Sequencing of Newly Diagnosed Multiple Myeloma to Identify a Predictive Signature for Proteasome Inhibitor-Based Therapy

Jonathan I Sive, MDPhD, John C Ambrose, PhD, Kwee L Yong, Claire Roddie, MD PhD, Nicholas Counsell, Paul Smith, Nivette Braganca, Toyin Adadayo, Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MDPhD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MDPhD, Josephine Crowe, MD, Michael F Quinn, MD, Shirley D'Sa, Andres Virchis, MD, Gordon Cook, MDPhD, Charles Crawley, Guy E Pratt, MDFRCP FRCPath, Mark Cook, PhDMBChB, Michael A Chapman, MDPhD
Journal: Blood
Blood (2016) 128 (22): 3267.
https://doi.org/10.1182/blood.V128.22.3267.3267
Published: 2016
Journal Articles

Analysis of HOXA5 and HOXB3 Expression Complements Conventional Cytogenetic Analysis in Acute Myeloid Leukemia.

Damian P.J. Finnegan, MRCP(UK), Vivien M. Hodges, PhD, Alexander Thompson, PhD, Michael F. Quinn, MD, Mervyn Humphries, PhD, Terence R.J. Lappin, PhD, Mary Frances McMullin, MD, Graham R. Ball, PhD
Journal: Blood
Blood (2007) 110 (11): 2388.
https://doi.org/10.1182/blood.V110.11.2388.2388
Published: 2007
Journal Articles

Artificial Neural Network Analysis of HOX Gene Expression Profiles Predicts Prognostic Subgroups in Acute Myeloid Leukemia.

Damian P.J. Finnegan, MRCP (UK), Michael F. Quinn, MD, Mervyn Humphreys, PhD, Terence R.J. Lappin, PhD, Mary Frances McMullin, MD, Alexander Thompson, PhD, Graham R. Ball, PhD
Journal: Blood
Blood (2006) 108 (11): 2318.
https://doi.org/10.1182/blood.V108.11.2318.2318
Published: 2006